Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yun-Jian Sheng
Lamivudine Plus Adefovir Combination Therapy Versus Entecavir Monotherapy for Lamivudine-Resistant Chronic Hepatitis B: A Systematic Review and Meta-Analysis
Virology Journal
Virology
Infectious Diseases
Related publications
Impact of Lamivudine Plus Adefovir Therapy in Chronic Hepatitis B Iranian Patients, Resistant to Lamivudine Treatment Alone, on Disease Inhibition: A Pilot Study
Open Journal of Gastroenterology
Erratum To: Add-On Adefovir Is Superior to a Switch to Entecavir as Rescue Therapy for Lamivudine-Resistant Chronic Hepatitis B
Digestive Diseases and Sciences
Physiology
Gastroenterology
Resistance to Adefovir Dipivoxil in Lamivudine Resistant Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil
Gut
Gastroenterology
Renal Dysfunction and Hypophosphatemia During Long-Term Lamivudine Plus Adefovir Dipivoxil Therapy in Patients With Chronic Hepatitis B
Journal of Gastroenterology
Gastroenterology
The Efficacy of Adefovir Dipivoxil Monotherapy and the Incidence of Genotypic Resistance to Adefovir Dipivoxil in Patients With Lamivudine-Resistant Chronic Hepatitis B Infection
The Korean Journal of Hepatology
Comparison of the Clinical Outcomes Between Antiviral-Naïve Patients Treated With Entecavir and Lamivudine-Resistant Patients Receiving Adefovir Add-On Lamivudine Combination Treatment
Clinical and molecular hepatology
Medicine
Hepatology
Molecular Biology
Evaluation of Long-Term Entecavir Treatment in Stable Chronic Hepatitis B Patients Switched From Lamivudine Therapy
Hepatology International
Hepatology
Immunomodulatory Effects of Combination Therapy With Bushen Formula Plus Entecavir for Chronic Hepatitis B Patients
Journal of Immunology Research
Medicine
Allergy
Immunology
The Effect of Prophylactic Lamivudine Plus Adefovir Therapy Compared With Lamivudine Alone in Preventing Hepatitis B Reactivation in Lymphoma Patients With High Baseline HBV DNA During Chemotherapy
PLoS ONE
Multidisciplinary
